Publicacions en col·laboració amb investigadors/es de Hospital General Universitario de Alicante (15)

2022

  1. Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss

    American Journal of Transplantation, Vol. 22, Núm. 4, pp. 1169-1181

  2. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients

    Transplantation, Vol. 106, Núm. 7, pp. 1430-1439

  3. Incidence of Lymphoproliferative Disorders After Renal Transplantation is Down, but the Poor Prognosis Remains. Multicenter 32-Year Cohort Study.

    Transplantation Proceedings, Vol. 54, Núm. 9, pp. 2462-2466

2020

  1. Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients

    Nefrologia, Vol. 40, Núm. 3, pp. 265-271

2019

  1. A survey of Heads of Surgery and Residents on accessibility and employment in liver transplant teams in Spain

    Cirugia Espanola, Vol. 97, Núm. 10, pp. 560-567

  2. Apolipoprotein A-Ib as a biomarker of focal segmental glomerulosclerosis recurrence after kidney transplantation: diagnostic performance and assessment of its prognostic value – a multi-centre cohort study

    Transplant International, Vol. 32, Núm. 3, pp. 313-322

  3. Direct-Acting Antivirals for the Treatment of Kidney Transplant Patients with Chronic Hepatitis C Virus Infection in Spain: A Long-Term Prospective Observational Study

    Transplantation Direct, Vol. 5, Núm. 12

  4. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation

    Journal of Hepatology, Vol. 70, Núm. 4, pp. 658-665

  5. Reply to: “Normothermic regional perfusion – What is the benefit?”

    Journal of Hepatology

  6. The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation

    Journal of Hepatology

2015

  1. Medium-Term Renal Function in a Large Cohort of Stable Kidney Transplant Recipients Converted from Twice-Daily to Once-Daily Tacrolimus

    Transplantation Direct, Vol. 1, Núm. 7, pp. E24

  2. V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante

    Cirugia Espanola, Vol. 93, Núm. 10, pp. 619-637

2013

  1. Early-onset anemia after kidney transplantation is an independent factor for graft loss: A multicenter, observational cohort study

    Transplantation, Vol. 96, Núm. 8, pp. 717-725

2011

  1. Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients

    American Journal of Transplantation, Vol. 11, Núm. 9, pp. 1965-1971

2007

  1. Gastrointestinal Complications in Renal Transplant Recipients: MITOS Study

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2190-2193